Literature DB >> 19263315

[Procalcitonin (PCT) as diagnostic tool for the monitoring of spondylodiscitis].

U Maus1, S Andereya, S Gravius, J A K Ohnsorge, O Miltner, C Niedhart.   

Abstract

AIM: The diagnosis of spondylodiscitis is often prolonged, but it is an important differential diagnosis of backache. The discrimination between a bacterial infection and an aseptic inflammation with laboratory examinations like ESG, CRP or leukocytes is not possible. The aim of the present study was to determine the value of procalcitonin (PCT) as a diagnostic tool and monitoring parameter for spondylodiscitis and for the discrimination between bacterial infection and aseptic inflammation of the spine.
METHOD: A total of 17 patients with spondylodiscitis and 18 patients with disc herniation as control were included in this study and ESG, CRP, leukocytes, fibrinogen, PNM elastase und PCT were examined for 50 days. The median age was 65 (17-78) years and the ratio of males to females was 8 : 9 in patients with spondylodiscitis and 62 (32-87) years and 7 : 11 in patients with disc herniation. For microbiological examination, CT-guided punctures were performed in patients with spondylodiscitis.
RESULTS: In 64 % of the 17 patients with spondylodiscitis a microbiological agent was detected, in 73 % of these cases staphylococcus aureus was isolated. The laboratory parameters indicating an infection were increased except for two cases in patients with spondylodiscitis, the mean value of CRP was 115 mg/dL. Influenced by the therapy these parameters decreased during the observation period. Except for one patient with an infection of a cardiac pacemaker, the PCT concentration was not elevated in both groups (< 0.5 ng/mL). In the group with disc herniation there were no elevated laboratory parameters during the entire observation period.
CONCLUSION: PCT is not useful as diagnostic tool or monitoring parameter for spondylodiscitis. Furthermore, it is not useful for the discrimination between a bacterial infection and an aseptic inflammation of the spine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19263315     DOI: 10.1055/s-2008-1038974

Source DB:  PubMed          Journal:  Z Orthop Unfall        ISSN: 1864-6697            Impact factor:   0.923


  6 in total

1.  Spondylodiscitis severity code: scoring system for the classification and treatment of non-specific spondylodiscitis.

Authors:  L Homagk; N Homagk; J R Klauss; K Roehl; G O Hofmann; D Marmelstein
Journal:  Eur Spine J       Date:  2015-04-21       Impact factor: 3.134

2.  Spondylodiscitis: Diagnosis and Treatment Options.

Authors:  Christian Herren; Norma Jung; Miguel Pishnamaz; Marianne Breuninger; Jan Siewe; Rolf Sobottke
Journal:  Dtsch Arztebl Int       Date:  2017-12-25       Impact factor: 5.594

Review 3.  Surgical site infections following spine surgery: eliminating the controversies in the diagnosis.

Authors:  Jad Chahoud; Zeina Kanafani; Souha S Kanj
Journal:  Front Med (Lausanne)       Date:  2014-03-24

4.  Changes of Biomarkers before and after Antibiotic Treatment in Spinal Infection.

Authors:  Young Lee; Jeongwook Lim; Seung-Won Choi; Sanghyun Han; Bumsoo Park; Jin-Young Youm
Journal:  Korean J Neurotrauma       Date:  2019-08-28

5.  Admission inflammatory markers and isolation of a causative organism in patients with spontaneous spinal infection.

Authors:  P A G Torrie; A Leonidou; I J Harding; G Wynne Jones; M J Hutchinson; I W Nelson
Journal:  Ann R Coll Surg Engl       Date:  2013-11       Impact factor: 1.951

6.  Procalcitonin -Vital Tool to Differentiate Septic Progression of Spondylodiscitis from Drug Hypersensitivity: A Case Report and Brief Review of Literature.

Authors:  Saurabh Kapoor; Akshay D Gadiya; Fahid T Rasul; David Bell
Journal:  J Orthop Case Rep       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.